nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—psoriasis—skin cancer	0.528	1	CtDrD
Triamcinolone—PTGS2—skin cancer	0.26	1	CbGaD
Triamcinolone—CYP3A4—Imiquimod—skin cancer	0.0322	0.292	CbGbCtD
Triamcinolone—CYP3A4—Temozolomide—skin cancer	0.0322	0.292	CbGbCtD
Triamcinolone—CYP3A4—Vismodegib—skin cancer	0.0223	0.202	CbGbCtD
Triamcinolone—CYP3A4—Vemurafenib—skin cancer	0.0176	0.16	CbGbCtD
Triamcinolone—CYP3A4—Docetaxel—skin cancer	0.00605	0.0548	CbGbCtD
Triamcinolone—Fluocinonide—SMO—skin cancer	0.00155	0.901	CrCbGaD
Triamcinolone—PTGS2—leg—skin cancer	0.00128	0.0954	CbGeAlD
Triamcinolone—PTGS2—hindlimb—skin cancer	0.00114	0.0852	CbGeAlD
Triamcinolone—PTGS2—appendage—skin cancer	0.000982	0.0731	CbGeAlD
Triamcinolone—PTGS2—skin epidermis—skin cancer	0.000817	0.0608	CbGeAlD
Triamcinolone—NR3C1—nerve—skin cancer	0.000804	0.0599	CbGeAlD
Triamcinolone—PTGS2—endothelium—skin cancer	0.000593	0.0441	CbGeAlD
Triamcinolone—PTGS2—blood vessel—skin cancer	0.000547	0.0407	CbGeAlD
Triamcinolone—SERPINA6—female reproductive system—skin cancer	0.000521	0.0388	CbGeAlD
Triamcinolone—BCHE—nipple—skin cancer	0.000513	0.0382	CbGeAlD
Triamcinolone—NR3C1—nipple—skin cancer	0.000457	0.034	CbGeAlD
Triamcinolone—NR3C1—neck—skin cancer	0.000452	0.0336	CbGeAlD
Triamcinolone—SERPINA6—head—skin cancer	0.000436	0.0324	CbGeAlD
Triamcinolone—BCHE—skin of body—skin cancer	0.000328	0.0245	CbGeAlD
Triamcinolone—NR3C1—connective tissue—skin cancer	0.000324	0.0241	CbGeAlD
Triamcinolone—NR3C1—epithelium—skin cancer	0.000307	0.0229	CbGeAlD
Triamcinolone—BCHE—mammalian vulva—skin cancer	0.0003	0.0223	CbGeAlD
Triamcinolone—NR3C1—skin of body—skin cancer	0.000292	0.0218	CbGeAlD
Triamcinolone—Vascular purpura—Temozolomide—skin cancer	0.000292	0.00339	CcSEcCtD
Triamcinolone—Asthenia—Vismodegib—skin cancer	0.000292	0.00339	CcSEcCtD
Triamcinolone—Pruritus—Vismodegib—skin cancer	0.000288	0.00334	CcSEcCtD
Triamcinolone—Euphoric mood—Fluorouracil—skin cancer	0.000285	0.00331	CcSEcCtD
Triamcinolone—PTGS2—connective tissue—skin cancer	0.00028	0.0209	CbGeAlD
Triamcinolone—Thrombophlebitis—Fluorouracil—skin cancer	0.000278	0.00323	CcSEcCtD
Triamcinolone—Purpura—Temozolomide—skin cancer	0.000271	0.00314	CcSEcCtD
Triamcinolone—Arrhythmia—Imiquimod—skin cancer	0.00027	0.00313	CcSEcCtD
Triamcinolone—Cough—Vemurafenib—skin cancer	0.000269	0.00312	CcSEcCtD
Triamcinolone—NR3C1—mammalian vulva—skin cancer	0.000267	0.0199	CbGeAlD
Triamcinolone—PTGS2—epithelium—skin cancer	0.000266	0.0198	CbGeAlD
Triamcinolone—Oropharyngeal pain—Docetaxel—skin cancer	0.000263	0.00305	CcSEcCtD
Triamcinolone—Erythema—Imiquimod—skin cancer	0.000263	0.00305	CcSEcCtD
Triamcinolone—Myalgia—Vemurafenib—skin cancer	0.000262	0.00304	CcSEcCtD
Triamcinolone—Vomiting—Vismodegib—skin cancer	0.000259	0.003	CcSEcCtD
Triamcinolone—Affect lability—Temozolomide—skin cancer	0.000257	0.00298	CcSEcCtD
Triamcinolone—Rash—Vismodegib—skin cancer	0.000257	0.00297	CcSEcCtD
Triamcinolone—BCHE—female reproductive system—skin cancer	0.000256	0.0191	CbGeAlD
Triamcinolone—Dermatitis—Vismodegib—skin cancer	0.000256	0.00297	CcSEcCtD
Triamcinolone—Back pain—Imiquimod—skin cancer	0.000254	0.00295	CcSEcCtD
Triamcinolone—PTGS2—skin of body—skin cancer	0.000253	0.0188	CbGeAlD
Triamcinolone—Dermatitis bullous—Fluorouracil—skin cancer	0.000252	0.00292	CcSEcCtD
Triamcinolone—Anaphylactic shock—Vemurafenib—skin cancer	0.000251	0.00291	CcSEcCtD
Triamcinolone—Infection—Vemurafenib—skin cancer	0.00025	0.0029	CcSEcCtD
Triamcinolone—Mood swings—Temozolomide—skin cancer	0.000248	0.00287	CcSEcCtD
Triamcinolone—Ill-defined disorder—Imiquimod—skin cancer	0.000244	0.00283	CcSEcCtD
Triamcinolone—Nausea—Vismodegib—skin cancer	0.000242	0.0028	CcSEcCtD
Triamcinolone—Osteoarthritis—Fluorouracil—skin cancer	0.000241	0.00279	CcSEcCtD
Triamcinolone—Angioedema—Imiquimod—skin cancer	0.00024	0.00278	CcSEcCtD
Triamcinolone—Malaise—Imiquimod—skin cancer	0.000237	0.00275	CcSEcCtD
Triamcinolone—NR3C1—lymphoid tissue—skin cancer	0.000237	0.0176	CbGeAlD
Triamcinolone—Syncope—Imiquimod—skin cancer	0.000236	0.00273	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Bleomycin—skin cancer	0.000235	0.00273	CcSEcCtD
Triamcinolone—Myocardial infarction—Bleomycin—skin cancer	0.000234	0.00271	CcSEcCtD
Triamcinolone—Loss of consciousness—Imiquimod—skin cancer	0.000231	0.00268	CcSEcCtD
Triamcinolone—Muscular weakness—Temozolomide—skin cancer	0.000231	0.00267	CcSEcCtD
Triamcinolone—Cough—Imiquimod—skin cancer	0.000229	0.00266	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000229	0.00266	CcSEcCtD
Triamcinolone—Cardiac arrest—Fluorouracil—skin cancer	0.000229	0.00266	CcSEcCtD
Triamcinolone—Candida infection—Docetaxel—skin cancer	0.000229	0.00265	CcSEcCtD
Triamcinolone—Skin exfoliation—Docetaxel—skin cancer	0.000229	0.00265	CcSEcCtD
Triamcinolone—NR3C1—female reproductive system—skin cancer	0.000228	0.017	CbGeAlD
Triamcinolone—Convulsion—Imiquimod—skin cancer	0.000228	0.00264	CcSEcCtD
Triamcinolone—Abdominal distension—Temozolomide—skin cancer	0.000227	0.00264	CcSEcCtD
Triamcinolone—Fluid retention—Docetaxel—skin cancer	0.000227	0.00264	CcSEcCtD
Triamcinolone—Hypertension—Imiquimod—skin cancer	0.000227	0.00263	CcSEcCtD
Triamcinolone—Neuropathy—Docetaxel—skin cancer	0.000225	0.00261	CcSEcCtD
Triamcinolone—Myalgia—Imiquimod—skin cancer	0.000224	0.00259	CcSEcCtD
Triamcinolone—Discomfort—Imiquimod—skin cancer	0.000221	0.00256	CcSEcCtD
Triamcinolone—Sweating increased—Temozolomide—skin cancer	0.00022	0.00255	CcSEcCtD
Triamcinolone—Dry mouth—Imiquimod—skin cancer	0.000219	0.00254	CcSEcCtD
Triamcinolone—Bronchitis—Temozolomide—skin cancer	0.000217	0.00252	CcSEcCtD
Triamcinolone—Fatigue—Vemurafenib—skin cancer	0.000217	0.00251	CcSEcCtD
Triamcinolone—Haemoglobin—Bleomycin—skin cancer	0.000215	0.0025	CcSEcCtD
Triamcinolone—Oedema—Imiquimod—skin cancer	0.000214	0.00249	CcSEcCtD
Triamcinolone—Haemorrhage—Bleomycin—skin cancer	0.000214	0.00249	CcSEcCtD
Triamcinolone—BCHE—head—skin cancer	0.000214	0.016	CbGeAlD
Triamcinolone—Pulmonary oedema—Docetaxel—skin cancer	0.000213	0.00247	CcSEcCtD
Triamcinolone—Infection—Imiquimod—skin cancer	0.000213	0.00247	CcSEcCtD
Triamcinolone—Muscular weakness—Fluorouracil—skin cancer	0.000212	0.00246	CcSEcCtD
Triamcinolone—Shock—Imiquimod—skin cancer	0.000211	0.00245	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Temozolomide—skin cancer	0.00021	0.00243	CcSEcCtD
Triamcinolone—Tachycardia—Imiquimod—skin cancer	0.000209	0.00243	CcSEcCtD
Triamcinolone—Hyperhidrosis—Imiquimod—skin cancer	0.000207	0.0024	CcSEcCtD
Triamcinolone—Weight increased—Temozolomide—skin cancer	0.000206	0.00238	CcSEcCtD
Triamcinolone—PTGS2—lymphoid tissue—skin cancer	0.000205	0.0153	CbGeAlD
Triamcinolone—Thrombophlebitis—Docetaxel—skin cancer	0.000201	0.00233	CcSEcCtD
Triamcinolone—Body temperature increased—Vemurafenib—skin cancer	0.000199	0.0023	CcSEcCtD
Triamcinolone—Pharyngitis—Dactinomycin—skin cancer	0.000198	0.0023	CcSEcCtD
Triamcinolone—PTGS2—female reproductive system—skin cancer	0.000198	0.0147	CbGeAlD
Triamcinolone—Neuropathy peripheral—Temozolomide—skin cancer	0.000197	0.00229	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000195	0.00226	CcSEcCtD
Triamcinolone—Insomnia—Imiquimod—skin cancer	0.000194	0.00225	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000193	0.00224	CcSEcCtD
Triamcinolone—Paraesthesia—Imiquimod—skin cancer	0.000192	0.00223	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Docetaxel—skin cancer	0.000192	0.00222	CcSEcCtD
Triamcinolone—Dyspnoea—Imiquimod—skin cancer	0.000191	0.00222	CcSEcCtD
Triamcinolone—NR3C1—head—skin cancer	0.000191	0.0142	CbGeAlD
Triamcinolone—Dyspepsia—Imiquimod—skin cancer	0.000189	0.00219	CcSEcCtD
Triamcinolone—Erythema—Bleomycin—skin cancer	0.000187	0.00216	CcSEcCtD
Triamcinolone—Hypersensitivity—Vemurafenib—skin cancer	0.000185	0.00215	CcSEcCtD
Triamcinolone—Fatigue—Imiquimod—skin cancer	0.000185	0.00214	CcSEcCtD
Triamcinolone—Pain—Imiquimod—skin cancer	0.000183	0.00213	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Fluorouracil—skin cancer	0.000183	0.00212	CcSEcCtD
Triamcinolone—Myocardial infarction—Fluorouracil—skin cancer	0.000182	0.00211	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Fluorouracil—skin cancer	0.000182	0.00211	CcSEcCtD
Triamcinolone—Dermatitis bullous—Docetaxel—skin cancer	0.000182	0.00211	CcSEcCtD
Triamcinolone—Haemoglobin—Temozolomide—skin cancer	0.000182	0.00211	CcSEcCtD
Triamcinolone—Haemorrhage—Temozolomide—skin cancer	0.000181	0.0021	CcSEcCtD
Triamcinolone—Conjunctivitis—Fluorouracil—skin cancer	0.00018	0.00209	CcSEcCtD
Triamcinolone—Asthenia—Vemurafenib—skin cancer	0.00018	0.00209	CcSEcCtD
Triamcinolone—Pharyngitis—Temozolomide—skin cancer	0.000179	0.00208	CcSEcCtD
Triamcinolone—Pruritus—Vemurafenib—skin cancer	0.000178	0.00206	CcSEcCtD
Triamcinolone—Feeling abnormal—Imiquimod—skin cancer	0.000177	0.00205	CcSEcCtD
Triamcinolone—Epistaxis—Fluorouracil—skin cancer	0.000175	0.00203	CcSEcCtD
Triamcinolone—Erythema—Dactinomycin—skin cancer	0.000174	0.00202	CcSEcCtD
Triamcinolone—Ill-defined disorder—Bleomycin—skin cancer	0.000173	0.00201	CcSEcCtD
Triamcinolone—CYP3A4—female reproductive system—skin cancer	0.000173	0.0129	CbGeAlD
Triamcinolone—Urticaria—Imiquimod—skin cancer	0.00017	0.00197	CcSEcCtD
Triamcinolone—Body temperature increased—Imiquimod—skin cancer	0.000169	0.00197	CcSEcCtD
Triamcinolone—Malaise—Bleomycin—skin cancer	0.000168	0.00195	CcSEcCtD
Triamcinolone—Haemoglobin—Fluorouracil—skin cancer	0.000167	0.00194	CcSEcCtD
Triamcinolone—Rhinitis—Fluorouracil—skin cancer	0.000167	0.00194	CcSEcCtD
Triamcinolone—Haemorrhage—Fluorouracil—skin cancer	0.000167	0.00193	CcSEcCtD
Triamcinolone—Dizziness—Vemurafenib—skin cancer	0.000166	0.00193	CcSEcCtD
Triamcinolone—Pharyngitis—Fluorouracil—skin cancer	0.000165	0.00192	CcSEcCtD
Triamcinolone—PTGS2—head—skin cancer	0.000165	0.0123	CbGeAlD
Triamcinolone—Cough—Bleomycin—skin cancer	0.000163	0.00189	CcSEcCtD
Triamcinolone—Ill-defined disorder—Dactinomycin—skin cancer	0.000161	0.00187	CcSEcCtD
Triamcinolone—Vomiting—Vemurafenib—skin cancer	0.00016	0.00185	CcSEcCtD
Triamcinolone—Myalgia—Bleomycin—skin cancer	0.000159	0.00184	CcSEcCtD
Triamcinolone—Rash—Vemurafenib—skin cancer	0.000158	0.00184	CcSEcCtD
Triamcinolone—Dermatitis—Vemurafenib—skin cancer	0.000158	0.00184	CcSEcCtD
Triamcinolone—Hypersensitivity—Imiquimod—skin cancer	0.000158	0.00183	CcSEcCtD
Triamcinolone—Headache—Vemurafenib—skin cancer	0.000157	0.00183	CcSEcCtD
Triamcinolone—Erythema—Temozolomide—skin cancer	0.000157	0.00183	CcSEcCtD
Triamcinolone—Discomfort—Bleomycin—skin cancer	0.000157	0.00182	CcSEcCtD
Triamcinolone—Malaise—Dactinomycin—skin cancer	0.000157	0.00182	CcSEcCtD
Triamcinolone—Dysgeusia—Temozolomide—skin cancer	0.000154	0.00179	CcSEcCtD
Triamcinolone—Asthenia—Imiquimod—skin cancer	0.000154	0.00178	CcSEcCtD
Triamcinolone—Anaphylactic shock—Bleomycin—skin cancer	0.000152	0.00177	CcSEcCtD
Triamcinolone—Oedema—Bleomycin—skin cancer	0.000152	0.00177	CcSEcCtD
Triamcinolone—Back pain—Temozolomide—skin cancer	0.000152	0.00177	CcSEcCtD
Triamcinolone—Pruritus—Imiquimod—skin cancer	0.000152	0.00176	CcSEcCtD
Triamcinolone—Infection—Bleomycin—skin cancer	0.000151	0.00175	CcSEcCtD
Triamcinolone—BCHE—lymph node—skin cancer	0.00015	0.0112	CbGeAlD
Triamcinolone—Nausea—Vemurafenib—skin cancer	0.000149	0.00173	CcSEcCtD
Triamcinolone—Arrhythmia—Fluorouracil—skin cancer	0.000149	0.00173	CcSEcCtD
Triamcinolone—Myalgia—Dactinomycin—skin cancer	0.000148	0.00172	CcSEcCtD
Triamcinolone—Discomfort—Dactinomycin—skin cancer	0.000146	0.0017	CcSEcCtD
Triamcinolone—Ill-defined disorder—Temozolomide—skin cancer	0.000146	0.00169	CcSEcCtD
Triamcinolone—Erythema—Fluorouracil—skin cancer	0.000145	0.00168	CcSEcCtD
Triamcinolone—Angioedema—Temozolomide—skin cancer	0.000144	0.00167	CcSEcCtD
Triamcinolone—Oedema—Dactinomycin—skin cancer	0.000142	0.00165	CcSEcCtD
Triamcinolone—Malaise—Temozolomide—skin cancer	0.000142	0.00165	CcSEcCtD
Triamcinolone—Dizziness—Imiquimod—skin cancer	0.000142	0.00164	CcSEcCtD
Triamcinolone—Vertigo—Temozolomide—skin cancer	0.000141	0.00164	CcSEcCtD
Triamcinolone—Infection—Dactinomycin—skin cancer	0.000141	0.00164	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000139	0.00161	CcSEcCtD
Triamcinolone—Cough—Temozolomide—skin cancer	0.000137	0.00159	CcSEcCtD
Triamcinolone—Paraesthesia—Bleomycin—skin cancer	0.000137	0.00159	CcSEcCtD
Triamcinolone—Weight increased—Docetaxel—skin cancer	0.000137	0.00159	CcSEcCtD
Triamcinolone—Convulsion—Temozolomide—skin cancer	0.000136	0.00158	CcSEcCtD
Triamcinolone—Vomiting—Imiquimod—skin cancer	0.000136	0.00158	CcSEcCtD
Triamcinolone—Hypertension—Temozolomide—skin cancer	0.000136	0.00158	CcSEcCtD
Triamcinolone—Dyspnoea—Bleomycin—skin cancer	0.000136	0.00157	CcSEcCtD
Triamcinolone—Rash—Imiquimod—skin cancer	0.000135	0.00157	CcSEcCtD
Triamcinolone—Dermatitis—Imiquimod—skin cancer	0.000135	0.00157	CcSEcCtD
Triamcinolone—Headache—Imiquimod—skin cancer	0.000134	0.00156	CcSEcCtD
Triamcinolone—Myalgia—Temozolomide—skin cancer	0.000134	0.00155	CcSEcCtD
Triamcinolone—NR3C1—lymph node—skin cancer	0.000134	0.00995	CbGeAlD
Triamcinolone—Discomfort—Temozolomide—skin cancer	0.000132	0.00154	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Docetaxel—skin cancer	0.000132	0.00153	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Docetaxel—skin cancer	0.000131	0.00152	CcSEcCtD
Triamcinolone—Myocardial infarction—Docetaxel—skin cancer	0.000131	0.00152	CcSEcCtD
Triamcinolone—Dry mouth—Temozolomide—skin cancer	0.000131	0.00152	CcSEcCtD
Triamcinolone—Pain—Bleomycin—skin cancer	0.00013	0.00151	CcSEcCtD
Triamcinolone—Conjunctivitis—Docetaxel—skin cancer	0.00013	0.00151	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000129	0.0015	CcSEcCtD
Triamcinolone—Anaphylactic shock—Temozolomide—skin cancer	0.000128	0.00149	CcSEcCtD
Triamcinolone—Oedema—Temozolomide—skin cancer	0.000128	0.00149	CcSEcCtD
Triamcinolone—Infection—Temozolomide—skin cancer	0.000128	0.00148	CcSEcCtD
Triamcinolone—Nausea—Imiquimod—skin cancer	0.000127	0.00148	CcSEcCtD
Triamcinolone—Epistaxis—Docetaxel—skin cancer	0.000126	0.00147	CcSEcCtD
Triamcinolone—Convulsion—Fluorouracil—skin cancer	0.000126	0.00146	CcSEcCtD
Triamcinolone—Feeling abnormal—Bleomycin—skin cancer	0.000125	0.00146	CcSEcCtD
Triamcinolone—Hyperhidrosis—Temozolomide—skin cancer	0.000124	0.00144	CcSEcCtD
Triamcinolone—Myalgia—Fluorouracil—skin cancer	0.000123	0.00143	CcSEcCtD
Triamcinolone—Fatigue—Dactinomycin—skin cancer	0.000122	0.00142	CcSEcCtD
Triamcinolone—Discomfort—Fluorouracil—skin cancer	0.000122	0.00141	CcSEcCtD
Triamcinolone—Pain—Dactinomycin—skin cancer	0.000121	0.00141	CcSEcCtD
Triamcinolone—Urticaria—Bleomycin—skin cancer	0.000121	0.0014	CcSEcCtD
Triamcinolone—Haemoglobin—Docetaxel—skin cancer	0.000121	0.0014	CcSEcCtD
Triamcinolone—Rhinitis—Docetaxel—skin cancer	0.000121	0.0014	CcSEcCtD
Triamcinolone—Body temperature increased—Bleomycin—skin cancer	0.00012	0.0014	CcSEcCtD
Triamcinolone—Haemorrhage—Docetaxel—skin cancer	0.00012	0.00139	CcSEcCtD
Triamcinolone—Pharyngitis—Docetaxel—skin cancer	0.000119	0.00138	CcSEcCtD
Triamcinolone—Anaphylactic shock—Fluorouracil—skin cancer	0.000118	0.00137	CcSEcCtD
Triamcinolone—Oedema—Fluorouracil—skin cancer	0.000118	0.00137	CcSEcCtD
Triamcinolone—Infection—Fluorouracil—skin cancer	0.000118	0.00136	CcSEcCtD
Triamcinolone—Feeling abnormal—Dactinomycin—skin cancer	0.000117	0.00136	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000117	0.00136	CcSEcCtD
Triamcinolone—Insomnia—Temozolomide—skin cancer	0.000116	0.00135	CcSEcCtD
Triamcinolone—PTGS2—lymph node—skin cancer	0.000116	0.00861	CbGeAlD
Triamcinolone—Tachycardia—Fluorouracil—skin cancer	0.000116	0.00134	CcSEcCtD
Triamcinolone—Paraesthesia—Temozolomide—skin cancer	0.000115	0.00134	CcSEcCtD
Triamcinolone—Dyspnoea—Temozolomide—skin cancer	0.000115	0.00133	CcSEcCtD
Triamcinolone—Dyspepsia—Temozolomide—skin cancer	0.000113	0.00131	CcSEcCtD
Triamcinolone—Body temperature increased—Dactinomycin—skin cancer	0.000112	0.0013	CcSEcCtD
Triamcinolone—Hypersensitivity—Bleomycin—skin cancer	0.000112	0.0013	CcSEcCtD
Triamcinolone—Fatigue—Temozolomide—skin cancer	0.000111	0.00128	CcSEcCtD
Triamcinolone—Pain—Temozolomide—skin cancer	0.00011	0.00127	CcSEcCtD
Triamcinolone—Asthenia—Bleomycin—skin cancer	0.000109	0.00127	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000108	0.00125	CcSEcCtD
Triamcinolone—Pruritus—Bleomycin—skin cancer	0.000108	0.00125	CcSEcCtD
Triamcinolone—Betamethasone—PTGS2—skin cancer	0.000108	0.0627	CrCbGaD
Triamcinolone—Arrhythmia—Docetaxel—skin cancer	0.000107	0.00125	CcSEcCtD
Triamcinolone—Insomnia—Fluorouracil—skin cancer	0.000107	0.00124	CcSEcCtD
Triamcinolone—Paraesthesia—Fluorouracil—skin cancer	0.000106	0.00123	CcSEcCtD
Triamcinolone—Feeling abnormal—Temozolomide—skin cancer	0.000106	0.00123	CcSEcCtD
Triamcinolone—Dyspnoea—Fluorouracil—skin cancer	0.000106	0.00122	CcSEcCtD
Triamcinolone—Erythema—Docetaxel—skin cancer	0.000105	0.00121	CcSEcCtD
Triamcinolone—Hypersensitivity—Dactinomycin—skin cancer	0.000105	0.00121	CcSEcCtD
Triamcinolone—Dyspepsia—Fluorouracil—skin cancer	0.000104	0.00121	CcSEcCtD
Triamcinolone—Dysgeusia—Docetaxel—skin cancer	0.000103	0.00119	CcSEcCtD
Triamcinolone—Urticaria—Temozolomide—skin cancer	0.000102	0.00118	CcSEcCtD
Triamcinolone—Asthenia—Dactinomycin—skin cancer	0.000102	0.00118	CcSEcCtD
Triamcinolone—Body temperature increased—Temozolomide—skin cancer	0.000102	0.00118	CcSEcCtD
Triamcinolone—Back pain—Docetaxel—skin cancer	0.000101	0.00117	CcSEcCtD
Triamcinolone—Pain—Fluorouracil—skin cancer	0.000101	0.00117	CcSEcCtD
Triamcinolone—Feeling abnormal—Fluorouracil—skin cancer	9.75e-05	0.00113	CcSEcCtD
Triamcinolone—Vomiting—Bleomycin—skin cancer	9.68e-05	0.00112	CcSEcCtD
Triamcinolone—Rash—Bleomycin—skin cancer	9.6e-05	0.00111	CcSEcCtD
Triamcinolone—Dermatitis—Bleomycin—skin cancer	9.59e-05	0.00111	CcSEcCtD
Triamcinolone—Hypersensitivity—Temozolomide—skin cancer	9.46e-05	0.0011	CcSEcCtD
Triamcinolone—Urticaria—Fluorouracil—skin cancer	9.4e-05	0.00109	CcSEcCtD
Triamcinolone—Syncope—Docetaxel—skin cancer	9.39e-05	0.00109	CcSEcCtD
Triamcinolone—Body temperature increased—Fluorouracil—skin cancer	9.36e-05	0.00109	CcSEcCtD
Triamcinolone—Asthenia—Temozolomide—skin cancer	9.22e-05	0.00107	CcSEcCtD
Triamcinolone—Loss of consciousness—Docetaxel—skin cancer	9.2e-05	0.00107	CcSEcCtD
Triamcinolone—Cough—Docetaxel—skin cancer	9.13e-05	0.00106	CcSEcCtD
Triamcinolone—Pruritus—Temozolomide—skin cancer	9.09e-05	0.00105	CcSEcCtD
Triamcinolone—Convulsion—Docetaxel—skin cancer	9.07e-05	0.00105	CcSEcCtD
Triamcinolone—Nausea—Bleomycin—skin cancer	9.05e-05	0.00105	CcSEcCtD
Triamcinolone—Hypertension—Docetaxel—skin cancer	9.04e-05	0.00105	CcSEcCtD
Triamcinolone—Vomiting—Dactinomycin—skin cancer	9.03e-05	0.00105	CcSEcCtD
Triamcinolone—Rash—Dactinomycin—skin cancer	8.95e-05	0.00104	CcSEcCtD
Triamcinolone—Myalgia—Docetaxel—skin cancer	8.91e-05	0.00103	CcSEcCtD
Triamcinolone—Hypersensitivity—Fluorouracil—skin cancer	8.72e-05	0.00101	CcSEcCtD
Triamcinolone—Dry mouth—Docetaxel—skin cancer	8.72e-05	0.00101	CcSEcCtD
Triamcinolone—Anaphylactic shock—Docetaxel—skin cancer	8.54e-05	0.000991	CcSEcCtD
Triamcinolone—Oedema—Docetaxel—skin cancer	8.54e-05	0.000991	CcSEcCtD
Triamcinolone—Dizziness—Temozolomide—skin cancer	8.49e-05	0.000985	CcSEcCtD
Triamcinolone—Infection—Docetaxel—skin cancer	8.49e-05	0.000984	CcSEcCtD
Triamcinolone—Nausea—Dactinomycin—skin cancer	8.44e-05	0.000978	CcSEcCtD
Triamcinolone—Shock—Docetaxel—skin cancer	8.4e-05	0.000975	CcSEcCtD
Triamcinolone—Pruritus—Fluorouracil—skin cancer	8.37e-05	0.000971	CcSEcCtD
Triamcinolone—Tachycardia—Docetaxel—skin cancer	8.34e-05	0.000967	CcSEcCtD
Triamcinolone—Vomiting—Temozolomide—skin cancer	8.17e-05	0.000947	CcSEcCtD
Triamcinolone—Rash—Temozolomide—skin cancer	8.1e-05	0.000939	CcSEcCtD
Triamcinolone—Dermatitis—Temozolomide—skin cancer	8.09e-05	0.000938	CcSEcCtD
Triamcinolone—Headache—Temozolomide—skin cancer	8.05e-05	0.000933	CcSEcCtD
Triamcinolone—Dizziness—Fluorouracil—skin cancer	7.83e-05	0.000908	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Docetaxel—skin cancer	7.78e-05	0.000903	CcSEcCtD
Triamcinolone—Insomnia—Docetaxel—skin cancer	7.73e-05	0.000896	CcSEcCtD
Triamcinolone—Paraesthesia—Docetaxel—skin cancer	7.67e-05	0.00089	CcSEcCtD
Triamcinolone—Nausea—Temozolomide—skin cancer	7.63e-05	0.000885	CcSEcCtD
Triamcinolone—Dyspnoea—Docetaxel—skin cancer	7.62e-05	0.000883	CcSEcCtD
Triamcinolone—Vomiting—Fluorouracil—skin cancer	7.53e-05	0.000873	CcSEcCtD
Triamcinolone—Dyspepsia—Docetaxel—skin cancer	7.52e-05	0.000872	CcSEcCtD
Triamcinolone—Rash—Fluorouracil—skin cancer	7.46e-05	0.000865	CcSEcCtD
Triamcinolone—Dermatitis—Fluorouracil—skin cancer	7.46e-05	0.000865	CcSEcCtD
Triamcinolone—Headache—Fluorouracil—skin cancer	7.41e-05	0.00086	CcSEcCtD
Triamcinolone—Fatigue—Docetaxel—skin cancer	7.37e-05	0.000854	CcSEcCtD
Triamcinolone—Pain—Docetaxel—skin cancer	7.31e-05	0.000847	CcSEcCtD
Triamcinolone—Feeling abnormal—Docetaxel—skin cancer	7.04e-05	0.000816	CcSEcCtD
Triamcinolone—Nausea—Fluorouracil—skin cancer	7.03e-05	0.000815	CcSEcCtD
Triamcinolone—Body temperature increased—Docetaxel—skin cancer	6.75e-05	0.000783	CcSEcCtD
Triamcinolone—Hypersensitivity—Docetaxel—skin cancer	6.29e-05	0.00073	CcSEcCtD
Triamcinolone—Dexamethasone—PTGS2—skin cancer	6.26e-05	0.0365	CrCbGaD
Triamcinolone—Asthenia—Docetaxel—skin cancer	6.13e-05	0.000711	CcSEcCtD
Triamcinolone—Pruritus—Docetaxel—skin cancer	6.04e-05	0.000701	CcSEcCtD
Triamcinolone—Dizziness—Docetaxel—skin cancer	5.65e-05	0.000655	CcSEcCtD
Triamcinolone—Vomiting—Docetaxel—skin cancer	5.43e-05	0.00063	CcSEcCtD
Triamcinolone—Rash—Docetaxel—skin cancer	5.39e-05	0.000625	CcSEcCtD
Triamcinolone—Dermatitis—Docetaxel—skin cancer	5.38e-05	0.000624	CcSEcCtD
Triamcinolone—Headache—Docetaxel—skin cancer	5.35e-05	0.000621	CcSEcCtD
Triamcinolone—Nausea—Docetaxel—skin cancer	5.07e-05	0.000588	CcSEcCtD
